Wallace Weitz’s Prestige Consumer Healthcare PBH Stock Holding History

Wallace Weitz’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-160,000	Closed	-$7.4M	–	69
2015 Q2	$7.4M	Hold	160,000	–	–	0.21%	58
2015 Q1	$6.86M	Hold	160,000	–	–	0.19%	55
2014 Q4	$5.55M	Hold	160,000	–	–	0.16%	58
2014 Q3	$5.18M	Buy	160,000 +35,000	+28%	+$1.17M	0.15%	58
2014 Q2	$4.24M	Hold	125,000	–	–	0.13%	54
2014 Q1	$3.41M	Sell	125,000 -25,000	-17%	-$743K	0.11%	56
2013 Q4	$5.37M	Hold	150,000	–	–	0.18%	53
2013 Q3	$4.52M	Sell	150,000 -100,000	-40%	-$3.27M	0.17%	52
2013 Q2	$7.29M	Buy	+250,000	New	+$7.05M	0.29%	47

Other funds holding PBH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wallace Weitz's PBH Position: Q3 2015 in Review

Wallace Weitz sold out of Prestige Consumer Healthcare (PBH) in Q3 2015, closing a stake of 160,000 shares — an estimated $7.4M sold.

Wallace Weitz first reported a position in PBH in Q2 2013 and held it in 9 quarters. The position peaked at $7.4M in Q2 2015. 207 funds tracked by Wall St. Rank hold PBH as of Q3 2015.

Wallace Weitz reported no remaining Prestige Consumer Healthcare position as of Q3 2015 after selling out during the quarter.
Wallace Weitz sold 160,000 Prestige Consumer Healthcare shares in Q3 2015, an estimated $7.4M.
Wallace Weitz first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 9 quarters.
Wallace Weitz's Prestige Consumer Healthcare position peaked at $7.4M in Q2 2015.
207 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2015.

Based on Weitz Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.